Summarized by Masters of Longevity from Fight Aging!.
Grip strength-focused piece introducing research on using handgrip as an aging biomarker to evaluate outcomes after currently offered gene therapies, inviting readers to consider methodological challenges and interpretation caveats.
Key Takeaways
- The genes delivered by these gene therapies include follistatin for muscle growth, VEGF for vascular growth, and some well-known genes hoped to improve the state of the aging body and brain such as telomerase , SIRT1 , and so forth.
- So it is interesting to see the Triple Helix folk here reporting on their experience in the use of grip strength as a biomarker of aging to assess the results of gene therapies intended to improve function.
- The best way to stress test a biomarker is to gather data on how it actually performs given a range of different types of regenerative or anti-aging therapy.
